Now that Pfizer's acquisition of Wyeth is complete, the cuts are coming -- this week, the pharma announced that it would shut down six of its 20 research facilities (with some question marks hanging over others). "Pfizer didn't say how many R&D jobs it would cut or how much it hoped to save from the shutdowns," according to this news analysis story from the Wall Street Journal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.